338 related articles for article (PubMed ID: 15948941)
1. Changes in availability of paediatric medicines in Australia between 1998 and 2002.
Chui J; Tordoff J; Reith D
Br J Clin Pharmacol; 2005 Jun; 59(6):736-42. PubMed ID: 15948941
[TBL] [Abstract][Full Text] [Related]
2. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
3. Pediatric licensing status and the availability of suitable formulations for new medical entities approved in the United States between 1998 and 2002.
Balakrishnan K; Grieve J; Tordoff J; Norris P; Reith D
J Clin Pharmacol; 2006 Sep; 46(9):1038-43. PubMed ID: 16920899
[TBL] [Abstract][Full Text] [Related]
4. Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998-2002.
Balakrishnan K; Tordoff J; Norris P; Reith D
Br J Clin Pharmacol; 2007 Jan; 63(1):85-91. PubMed ID: 16869822
[TBL] [Abstract][Full Text] [Related]
5. Effect of the pediatric exclusivity provision on children's access to medicines.
Grieve J; Tordoff J; Reith D; Norris P
Br J Clin Pharmacol; 2005 Jun; 59(6):730-5. PubMed ID: 15948940
[TBL] [Abstract][Full Text] [Related]
6. Trends in accessibility to medicines for children in New Zealand: 1998-2002.
Chui J; Tordoff J; Kennedy J; Reith D
Br J Clin Pharmacol; 2004 Mar; 57(3):322-7. PubMed ID: 14998428
[TBL] [Abstract][Full Text] [Related]
7. Paediatric formulations--getting to the heart of the problem.
Standing JF; Tuleu C
Int J Pharm; 2005 Aug; 300(1-2):56-66. PubMed ID: 15979830
[TBL] [Abstract][Full Text] [Related]
8. A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.
Ragupathy R; Aaltonen K; Tordoff J; Norris P; Reith D
Pharmacoeconomics; 2012 Nov; 30(11):1051-65. PubMed ID: 22963187
[TBL] [Abstract][Full Text] [Related]
9. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
10. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
[TBL] [Abstract][Full Text] [Related]
11. European perspectives on pediatric formulations.
Breitkreutz J
Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
[TBL] [Abstract][Full Text] [Related]
12. Access to prescribing information for paediatric medicines in the USA: post-modernization.
Young L; Lawes F; Tordoff J; Norris P; Reith D
Br J Clin Pharmacol; 2009 Mar; 67(3):341-6. PubMed ID: 19220278
[TBL] [Abstract][Full Text] [Related]
13. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
Giacoia GP; Taylor-Zapata P; Zajicek A
Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
[TBL] [Abstract][Full Text] [Related]
14. Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007.
Ragupathy R; Tordoff J; Norris P; Reith D
Pharm World Sci; 2010 Jun; 32(3):386-93. PubMed ID: 20354788
[TBL] [Abstract][Full Text] [Related]
15. Inappropriate oral formulations and information in paediatric trials.
Pandit S; Shah U; Kirby DJ; Nunn T; Tuleu C
Arch Dis Child; 2010 Sep; 95(9):754-6. PubMed ID: 20605870
[TBL] [Abstract][Full Text] [Related]
16. Access to new medicines in New Zealand compared to Australia.
Wonder M; Milne R
N Z Med J; 2011 Nov; 124(1346):12-28. PubMed ID: 22143849
[TBL] [Abstract][Full Text] [Related]
17. Formulation of medicines for children.
Nunn T; Williams J
Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
[TBL] [Abstract][Full Text] [Related]
18. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
Conroy S
Acta Paediatr; 2003 Apr; 92(4):408-10. PubMed ID: 12801103
[TBL] [Abstract][Full Text] [Related]
19. Developing paediatric medicines: identifying the needs and recognizing the challenges.
Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
[TBL] [Abstract][Full Text] [Related]
20. The availability and age-appropriateness of medicines authorized for children in The Netherlands.
van Riet-Nales DA; de Jager KE; Schobben AF; Egberts TC; Rademaker CM
Br J Clin Pharmacol; 2011 Sep; 72(3):465-73. PubMed ID: 21477143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
